HQL (abrdn Life Sciences Investors) Stock Analysis - Community
abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of May 21, 2026, HQL trades at $17.23 with a market cap of $537.31M and a P/E ratio of 0.00. HQL moved +1.41% today. Year to date, HQL is +6.90%; over the trailing twelve months it is +38.84%. Its 52-week range spans $10.55 to $18.46. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade HQL?
Rallies community data for HQL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Pittard Christian bought 7.92K (~$133.75K) on Dec 16, 2025.
Saba Capital Management, L.P. sold 41.62K (~$588.55K) on Sep 22, 2025.
Saba Capital Management, L.P. sold 6.99K (~$98.54K) on Sep 19, 2025.
HQL Analyst Consensus
HQL analyst coverage data. Average price target: $0.00.
Common questions about HQL
How does the Rallies community trade HQL?
Rallies community data for HQL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for HQL?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for HQL when enough community data is available.
Is HQL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HQL. It does not provide personalized investment advice.